snse: the income statement

MyFinsight

Sensei Biotherapeutics, Inc. (SNSE)

For the quarter ending 2025-06-30, SNSE made $321K in revenue. -$4,936K in net income. Net profit margin of -1537.69%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Other expense, net	-1
General and administrative	2,673
Research and development	2,533
Total operating expenses	5,206
Loss from operations	-5,206
Interest income	321
Interest expense	10
Loss on asset disposal	-40
Net loss	-4,936

Earnings per share, basic	-3.91
Earnings per share, diluted, total	-3.91
Weighted average number of shares outstanding, basic, total	1,260,867
Weighted average number of shares outstanding, diluted, total	1,260,867

Unit: Thousand (K) dollars (except for numbers of shares and EPS)